JP2024501659A5 - - Google Patents

Info

Publication number
JP2024501659A5
JP2024501659A5 JP2023537991A JP2023537991A JP2024501659A5 JP 2024501659 A5 JP2024501659 A5 JP 2024501659A5 JP 2023537991 A JP2023537991 A JP 2023537991A JP 2023537991 A JP2023537991 A JP 2023537991A JP 2024501659 A5 JP2024501659 A5 JP 2024501659A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
composition according
seq
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023537991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024501659A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/051521 external-priority patent/WO2022133519A1/en
Publication of JP2024501659A publication Critical patent/JP2024501659A/ja
Publication of JP2024501659A5 publication Critical patent/JP2024501659A5/ja
Pending legal-status Critical Current

Links

JP2023537991A 2020-12-21 2021-12-20 急性呼吸窮迫症候群を治療又は防止するための方法 Pending JP2024501659A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2020904755 2020-12-21
AU2020904755A AU2020904755A0 (en) 2020-12-21 Methods for treating or preventing acute respiratory distress syndrome
AU2021903362 2021-10-20
AU2021903362A AU2021903362A0 (en) 2021-10-20 Methods for treating or preventing acute respiratory distress syndrome
PCT/AU2021/051521 WO2022133519A1 (en) 2020-12-21 2021-12-20 Methods for treating or preventing acute respiratory distress syndrome

Publications (2)

Publication Number Publication Date
JP2024501659A JP2024501659A (ja) 2024-01-15
JP2024501659A5 true JP2024501659A5 (https=) 2024-12-03

Family

ID=82156881

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023537991A Pending JP2024501659A (ja) 2020-12-21 2021-12-20 急性呼吸窮迫症候群を治療又は防止するための方法

Country Status (7)

Country Link
US (1) US20230416381A1 (https=)
EP (1) EP4262872A4 (https=)
JP (1) JP2024501659A (https=)
KR (1) KR20230123477A (https=)
AU (1) AU2021408085A1 (https=)
CA (1) CA3198776A1 (https=)
WO (1) WO2022133519A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009006688A1 (en) * 2007-07-11 2009-01-15 Medvet Science Pty Ltd Regulating il-4 and il- 13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor
KR102385802B1 (ko) * 2014-05-07 2022-04-13 다케다 야쿠힝 고교 가부시키가이샤 Gm-csf 중화 화합물을 포함하는 액체 제제
AU2016361462B2 (en) * 2015-11-27 2023-09-21 Csl Limited CD131 binding proteins and uses thereof

Similar Documents

Publication Publication Date Title
EP1644039B1 (en) Compositions and methods for treating coagulation related disorders
RU2427589C2 (ru) Антитела против интерлейкина-13 человека и их применение
JP2024150751A5 (https=)
JP2008502366A5 (https=)
EP2777710A1 (en) Methods for administering anti-IL-5 antibodies
US11136388B2 (en) Biomarkers for anti-IL4-IL13 bispecific antibodies
US20240287170A1 (en) Methods for treating systemic sclerosis
JP2024501659A5 (https=)
CN117603358A (zh) 一种广谱新型冠状病毒的双特异性抗体
JP2025511929A5 (https=)
JP2023522971A (ja) 呼吸器疾患の治療のための汎elr+cxcケモカイン抗体
IL272676A (en) Biospecific antibodies against IL-4 and IL-13